Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review

• Hauptverfasser: Qiang Tong (Verfasst von), Peng-chong Zhu (Verfasst von), Zhuang Zhuang (Verfasst von), Li-hui Deng (Verfasst von), Zi-hao Wang (Verfasst von), Hua Zeng (Verfasst von), Guo-qing Zheng (Verfasst von), Yan Wang (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Notoginsenoside R1 (NGR1) exerts pharmacological actions for a variety of diseases such as myocardial infarction, ischemic stroke, acute renal injury, and intestinal injury. Here, we conducted a preclinical systematic review of NGR1 for ischemia reperfusion (I/R) injury. Eight databases were searche...